PBXIP1
(Pre-B-Cell Leukemia Homeobox Interacting Protein 1 (PBXIP1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-PBXIP1 antibody (Catalog #: ARP32948_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Aufreinigung
Purified
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
PBXIP1
(Pre-B-Cell Leukemia Homeobox Interacting Protein 1 (PBXIP1))
Synonyme
im:7138234 Peptide, wu:fb12b01 Peptide, zgc:158151 Peptide, 4732463H20Rik Peptide, HPIP Peptide, pre-B-cell leukemia homeobox interacting protein 1b Peptide, PBX homeobox interacting protein 1 Peptide, pre B cell leukemia transcription factor interacting protein 1 Peptide, pbxip1b Peptide, PBXIP1 Peptide, Pbxip1 Peptide
Hintergrund
PBXIP1 is the regulator of pre-B-cell leukemia transcription factors (BPXs) function. It inhibits the binding of PBX1-HOX complex to DNA and blocks the transcriptional activity of E2A-PBX1. PBXIP1 tethers estrogen receptor-alpha (ESR1) to microtubules and allows them to influence estrogen receptors-alpha signaling.
Alias Symbols: HPIP
Protein Interaction Partner: CCDC53,CCDC85B,DPPA2,TSNAX,UBQLN4,CCDC53,CCDC85B,DPPA2,TSNAX